Evidence map›Paper›PMID 33464535›Full record

ReviewJournal of molecular neuroscience : MN2021

Evidence of Coronavirus (CoV) Pathogenesis and Emerging Pathogen SARS-CoV-2 in the Nervous System: A Review on Neurological Impairments and Manifestations.

Niraj Kumar Jha, Shreesh Ojha, Saurabh Kumar Jha, Harish Dureja, Sachin Kumar Singh, Shakti D Shukla, Dinesh Kumar Chellappan, Gaurav Gupta, Shanu Bhardwaj, Neeraj Kumar and 10 more

Open access · bronzeAbstract readReview
In one paragraph

Review in Journal of molecular neuroscience : MN, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed, 2 pooled it
14.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 2 syntheses or guidelines pooled it, 146 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Neurological complications caused by SARS-CoV-2.Clinical microbiology reviews · 2024
    Review
  12. Article
  13. Article
  14. Opsoclonus-Myoclonus-Ataxia Syndrome Due to Covid-19.Cerebellum (London, England) · 2024
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 14 institutions in 5 countries.

Niraj Kumar JhaDepartment of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, 201310, UP, India. nirajkumarjha2011@gmail.com.ORCID http://orcid.org/0000-0001-9486-4069
Shreesh OjhaDepartment of Pharmacology and Therapeutics, College of Medicine and Health Sciences, PO Box - 17666, United Arab Emirates University, Al Ain, UAE.
Saurabh Kumar JhaDepartment of Biotechnology, School of Engineering & Technology (SET), Sharda University, Greater Noida, 201310, UP, India.
Harish DurejaFaculty of Pharmaceutical Sciences, Maharshi Dayanand University, Rohtak, India.
Sachin Kumar SinghSchool of Pharmaceutical Sciences, Lovely Professional University, Punjab, India.
Shakti D ShuklaPriority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, NSW, 2305, Australia.
Dinesh Kumar ChellappanDepartment of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.
Gaurav GuptaSchool of Pharmacy, Suresh Gyan Vihar University, Jagatpura, Mahal Road, Jaipur, India.
Shanu BhardwajDepartment of Biotechnology, HIMT, CCS University, Greater Noida, UP, India.
Neeraj KumarDepartment of Chemistry, University of Delhi, Delhi, 110007, India.
Madhan JeyaramanDepartment of Orthopaedics, School of Medical Sciences and Research, Sharda University, UP, 201310, Greater Noida, India.
Rashmi JainSchool of Medical Sciences and Research, Sharda University, UP, 201310, Greater Noida, India.
Sathish MuthuResearch Associate, Orthopaedic Research Group, Coimbatore, Tamil Nadu, India.
Rohan KarIndian Institute of Management Ahmedabad (IIMA), Gujarat, 380015, India.
Dhruv KumarAmity Institute of Molecular Medicine and Stem Cell Research (AIMMSCR), Amity University Uttar Pradesh, Noida, 201313, India.
Vineet Kumar GoswamiDepartment of Biological Sciences, School of Basic and Applied Sciences, G.D. Goenka University, G.D. Goenka Education City Sohna Gurugram Road, Haryana- 122103, India.
Janne RuokolainenDepartment of Applied Physics, School of Science, Aalto University, 00076, Espoo, Finland.
Kavindra Kumar KesariDepartment of Applied Physics, School of Science, Aalto University, 00076, Espoo, Finland.
Sandeep Kumar SinghCentre of Biomedical Research, SGPGI Campus, Lucknow, 226014, UP, India.
Kamal DuaPriority Research Centre for Healthy Lungs, Hunter Medical Research Institute (HMRI), University of Newcastle, New Lambton Heights, Newcastle, NSW, 2305, Australia.
Sharda University · INAalto University · FILovely Professional University · INAmity University · INGD Goenka University · INGyan Vihar University · INHunter Medical Research Institute · AUIMU University · MYIndian Institute of Management Ahmedabad · INMaharshi Dayanand University · INOrthopaedic Research Group · INUnited Arab Emirates University · AEUniversity of Delhi · INUniversity of Technology Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The coronavirus disease 2019 (COVID-19) pandemic is an issue of global significance that has taken the lives of many across the world. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the virus responsible for its pathogenesis. The pulmonary manifestations of COVID-19 have been well described in the literature. Initially, it was thought to be limited to the respiratory system; however, we now recognize that COVID-19 also affects several other organs, including the nervous system. Two similar human coronaviruses (CoV) that cause severe acute respiratory syndrome (SARS-CoV-1) and Middle East respiratory syndrome (MERS-CoV) are also known to cause disease in the nervous system. The neurological manifestations of SARS-CoV-2 infection are growing rapidly, as evidenced by several reports. There are several mechanisms responsible for such manifestations in the nervous system. For instance, post-infectious immune-mediated processes, direct virus infection of the central nervous system (CNS), and virus-induced hyperinflammatory and hypercoagulable states are commonly involved. Guillain-Barré syndrome (GBS) and its variants, dysfunction of taste and smell, and muscle injury are numerous examples of COVID-19 PNS (peripheral nervous system) disease. Likewise, hemorrhagic and ischemic stroke, encephalitis, meningitis, encephalopathy acute disseminated encephalomyelitis, endothelialitis, and venous sinus thrombosis are some instances of COVID-19 CNS disease. Due to multifactorial and complicated pathogenic mechanisms, COVID-19 poses a large-scale threat to the whole nervous system. A complete understanding of SARS-CoV-2 neurological impairments is still lacking, but our knowledge base is rapidly expanding. Therefore, we anticipate that this comprehensive review will provide valuable insights and facilitate the work of neuroscientists in unfolding different neurological dimensions of COVID-19 and other CoV associated abnormalities.

Indexed as

PandemicsAdolescentAdultAngiotensin-Converting Enzyme 2Asymptomatic InfectionsAutoimmune Diseases of the Nervous SystemBlood-Brain BarrierCerebrovascular DisordersChildCommunicable Diseases, EmergingCoronavirus InfectionsCOVID-19HumansHypoxiaNervous SystemNervous System DiseasesACE2 protein, humanAngiotensin-Converting Enzyme 2Receptors, VirusACE2Cerebrovascular diseaseCoronavirus (CoV)COVID-19Guillain-Barré syndrome (GBS)Multiple sclerosisNervous systemNeuropathogenesisSARS-CoV-2

Identifiers

PMID33464535
PMCPMC7814864
OpenAlexW3126049093

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.